3
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Lipids and atherosclerosis

A two-pronged approach to treatment

Pages 242-252 | Published online: 16 May 2016

References

  • Kannel WB, Doyle JT, Ostfeld AM, et al. Optimal resources for primary prevention of atherosclerotic diseases: atherosclerosis study group. Circulation 1984: 70(1): 155–205A
  • Mahley RW, Innerarity TL, Rall SC Jr, et al. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984: 25(12): 1277–94
  • Brewer HB Jr, Sprecher DL, Gregg RE, et al. Risk factore for the development of premature cardiovascular disease. Adv Exp Med Biol 1985: 183: 27–36
  • Maciejko JJ, Holmes DR, Kottke BA, et al. Apolipoprotein A-I as a marker of angiographically assesseds coronary artery disease. N Engl J Med 1983: 309(7): 385–9
  • Goldman L, Cook EF. The decline in ischemic heart disease mortality” rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984: 101 (6): 825–36
  • Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. 1. Reduction in incidence of coronary heart disease. JAMA 1984: 251 (3): 351–64
  • Merode TV, Hick P, Hocks AP, et al. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atheroscleroticlesions of the cervical carotid arteries in men. Stroke 1985:16(1): 34–8
  • Keys A, Karvonen MJ, Punsar S, et al. HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 1984: 13(4): 428–35
  • Green MS, Heiss G, Rifkind BM, et al. The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study. Circulation 1985: 72(1): 93–104
  • Lowering blood cholesterol to prevent heart disease. Nat Inst Health Consensus Dev Conf Consensus Statement 1985:5(7): 27
  • Rhoads GG, Dahlen G, Berg K, et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986:256(18): 2540–4
  • Schmidt SB, Wasserman AG, Muesing RA, et al. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol 1985: 55(13Pt1): 1459–62
  • Superko HR, Bachorlk PS, Wood PD. High-density lipoprotein cholesterol measurements: a help or hindrance in practical clinical medicine? JAMA 1986: 256(19): 2714–7
  • Arntzenius AC, Kromhont D, Barth JD, et al. Diet, lipoproteins, and the progression of coronaiy atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985:312(13): 805–11
  • Sacks FM, Handysides GH, Marais GE. et al. Effects of low-fat diet on plasma lipoprotein levels. Arch Intern Med 1986: 146(8): 1573–7
  • Tzagonrnis M. Triglycerides in clinical medicine: a review. Am J Clin Nutr 1978: 31(8): 1437–52
  • Gonen B, Patsch W, Kuisk I et al. Altered HDL subclasses in endogenous hypertriglyceridemia are not affected by weight reduction. Metabolism 1985: 34(5): 494–501
  • Kane JP, Malloy MJ, Tun P, et al. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med 1981:304(5): 251–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.